Detailed Information for N00095
IPAD-DB ID N00095
Name Solid Lipid Nanoparticles (SLNs)
Category Nano-inhibitors
EC50
IC50
Inhibition
Toxicity
ROS(reactive oxygen species)
Metal Chelating
BBB(blood-brain barrier) PASS
Target Protein
Effects (1) SLNs are unique lipid-based biocompatible nanocarrier systems;(2) SLNs have a solid hydrophobic lipid core, in which both hydrophilic and lipophilic drugs can be dispersed . They play a significant role in crossing the reticuloendothelial system (RES) of the BBB;(3) SLNs, as an advanced drug delivery approach, have been used to load the existing drugs, further improving bioavailability and therapeutic efficacy in treating AD
Research Models Drug Delivery System
Main Source
Ref. Link